Clinical Trials
9 trialsNCT01852890 2025-10-24
Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
University of Iowa
Phase 1 Completed
NCT03602235 2025-10-21
High Dose Ascorbic Acid for Plasma Cell Disorders
University of Iowa
Phase 1 Completed
NCT01752491 2024-12-20
A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
University of Iowa
Phase 1 Completed
NCT01891747 2022-03-10
A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma
Vanderbilt-Ingram Cancer Center
Phase 1 Completed
NCT01364805 2018-06-19
New Treatment Option for Pancreatic Cancer
University of Kansas Medical Center
Phase 1 Completed
NCT01833351 2015-11-06
Evaluation of Intravenous Ascorbic Acid
University of Kansas Medical Center
Phase 1 Completed
NCT00671697 2013-06-04
Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia
Washington University School of Medicine
Phase 1 Completed
NCT00258245 2013-04-29
Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT00441207 2013-04-23
Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors
Midwestern Regional Medical Center
Phase 1 Completed